期刊文献+

辅酶Q10对多巴胺损伤的PC12细胞凋亡的影响 被引量:6

Influence of coenzyme Q10 on PC12 apoptosis injured by Dopamine
下载PDF
导出
摘要 目的:观察辅酶Q10在以PC12细胞建立的多巴胺神经元凋亡细胞模型中的作用。方法:实验于2003-04/2004-04在锦州医学院科技试验中心进行。取体外培养的PC12细胞分为3组:①辅酶Q10组:加450μmol/L辅酶Q10和0.3mmol/L多巴胺。②多巴胺组:加0.3mmol/L多巴胺。③空白对照组:只加等量RPMI1640。24h后进行流式细胞仪测试DNA含量,检测细胞凋亡率。结果:多巴胺组细胞凋亡率明显高于空白对照组[(30.66±1.90)%,(0.82±0.07)%,P<0.01],辅酶Q10组细胞凋亡率[(16.05±2.16)%]明显低于多巴胺组(P<0.01)。结论:辅酶Q10能显著降低多巴胺引起的PC12细胞凋亡,提示辅酶Q10作为神经保护性药物对保护多巴胺能神经元,防治帕金森病可能有实际应用价值。 AIM:To observe the effect of coenzyme Q10 (Co Q10) on the model of dopaminergic neuron apoptosis based on PC12 cell. METHODS:The experiment was done in the Experimental Center of Science and Technology at Jinzhou Medical College from April 2003 to April 2004.The PC12 cells, cultured in vitro, were divided into 3 groups:(1) Co Q10 group:450 μmol/L Co Q10 and 0.3 mmol/L Dopamine (DA) was added to culture medium; (2)DA group:0.3 mmol/L DA was added to culture medium; (3)Control group:RPM11640 of same dose was added to culture medium. After 24 hours, the content of DNA was tested with flow cytometer and the apoptosis rate was detected. RESULTS:The apoptosis rate in groups of Co QlO [(16.05±2.16)%] and Control [(0.82±0.07)%] were remarkably lower than that of DA group [(30.66±1.90)%](P 〈 0.01 ). CONCLUSION:Co Q10 can significantly reduce the PC12 apoptosis induced by DA. It is indicated that Co Q10, as a neuroprotective drug, possibly has an application value in the protection of dopaminergic neuron and the treatment of Parkinson disease.
出处 《中国临床康复》 CSCD 北大核心 2005年第45期32-33,共2页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献8

  • 1Jankovic J.Levodopa strengths and weaknesses.Neurology 2002;58 (4 Suppl 1):19-32.
  • 2Shults CW,Haas RH,Passov D,et al.Coenzyme Q10 levels correlate with the activities of complexes Ⅰ and Ⅱ/Ⅲ in mitochondria from parkinsonian and nonparkinsonian subjects.Ann Neurol 1997;42(2):261-4.
  • 3Stocchi F,Olanow CW.Neuroprotection in Parkinson's disease:Clinical trials.Ann Neurol 2003 ;53(suppl 3):87-99.
  • 4Ravina BM,Fagan SC,Hart RG,et al.Neuroprotective agents for clinical trials in Parkinson' s disease:a systematic assessment.Neurology 2003;60:1234-40.
  • 5Yoo MS,Chun HS,Son JJ,et al.Oxidative stress regulated genes in nigral dopaminergic neuronal cell:correlation with the known pathology in Parkinson's disease.Brain Res Mol Brain Res 2003;110(1):76-84.
  • 6Viswanath V,Wu Y,Boonplueang R,et al.Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6,-tetrahydro-pyridine-induc-ed Parkinson's disease.Neurosci 2001;21 (24):9519-28.
  • 7Tatton WG,Chalmens-redman R,Brown D,et al.Apoptosis in Parkinson's disease:signals for neuronal degradation.A nn Neurol 2003;53(Suppl 3):61-70.
  • 8罗俊.辅酶Q_(10)与心肌缺血再灌注损伤[J].国外医学(麻醉学与复苏分册),1996,17(6):366-369. 被引量:3

二级参考文献4

共引文献2

同被引文献102

引证文献6

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部